Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.FDA approves ISTA BromDay solution
BromDay is designed for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract extraction. ISTA expects to launch BromDay (formerly referred
BromDay is designed for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract extraction. ISTA expects to launch BromDay (formerly referred
HP Acthar Gel is a natural adrenocorticotropic hormone (ACTH) designed to provide a prolonged release after intramuscular or subcutaneous injection. Acthar is currently approved in the US for
The patent covers the polymorph representing a preferred stable form of entinostat (SNDX-275 formerly MS-275) with key claims covering the polymorph form B and the manufacturing process by
The risk of disability progression (sustained for 12 weeks) was also reduced by 30% for the 14mg dose and numerically reduced by 24% for the 7mg dose, Sanofi-aventis
Merck and Co Inc’s Hyzaar, generically known as Losartan Potassium and Hydrochlorothiazide (HCTZ) tablets, is a combination medication used in the treatment of high blood pressure. Losartan, belongs
Pharmaserve-Lilly is a joint venture between Greece-based Pharmaserve and Eli Lilly and Company. The agreement will be automatically renewed for one-year periods, unless either party notifies the other
Watson claims that its Amlodipine Besylate/Benazepril capsules are generic equivalent to Novartis’ Lotrel capsules, which are indicated to prevent and treat high blood pressure. Lotrel is a combination
Following the approval, the company expects to launch the drug in the US market, and it will commence the shipments shortly. Lansoprazole delayed-release capsules are a combination package
Most recently, Burlington worked as the group vice president of Applications and Technology at Taleo Corporation. Prior to that, he served as senior vice president of Product Development
As of 30 June 2010 Zenith Pharmaceuticals owned 19.03% stake in Strides Arcolab, VCCircle reported. The deal valued the Bangalore-based company at INR17.46bn. Zenith sold 7.98 million shares